| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |